J Cancer 2021; 12(6):1742-1754. doi:10.7150/jca.51321 This issue Cite

Research Paper

AURKA and FAM83A are prognostic biomarkers and correlated with Tumor-infiltrating Lymphocytes in smoking related Lung Adenocarcinoma

Mengyu Zhang1, Chen Huo1, Yingxiao Jiang1, Jianyu Liu1, Yican Yang1, Yunhong Yin2, Yiqing Qu2✉

1. Department of Pulmonary and Critical Care Medicine, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250012, China.
2. Department of Pulmonary and Critical Care Medicine, Qilu Hospital of Shandong University, Jinan 250012, China.

Citation:
Zhang M, Huo C, Jiang Y, Liu J, Yang Y, Yin Y, Qu Y. AURKA and FAM83A are prognostic biomarkers and correlated with Tumor-infiltrating Lymphocytes in smoking related Lung Adenocarcinoma. J Cancer 2021; 12(6):1742-1754. doi:10.7150/jca.51321. https://www.jcancer.org/v12p1742.htm
Other styles

File import instruction

Abstract

Graphic abstract

Lung adenocarcinoma (LUAD) has become the main histologic type, which account for nearly 40% of lung cancer. The present study aimed to investigate the gene expression signature in smoking related LUAD. A total of 45 smoking related DEGs in LUAD were identified and functional enrichment analysis was also performed. Then Cox's regression model and Kaplan-Meier analysis were used to screen potential prognostic genes. Finally, AURKA and FAM83A were left for further immune-related mechanism exploration. Kaplan-Meier analysis indicated survival rates are related to different immune cell (B cell and Dendritic cell) infiltration levels. Mechanistically, we further explore the correlation between AURKA and FAM83A gene expression levels and tumor-infiltrating lymphocytes (TILs) level as well as their response to immunomodulators. The results suggested that AURKA and FAM83A are highly expressed in smoking related LUAD, and negatively correlated to B cell and Dendritic cell infiltration levels. At the same time, B cell and Dendritic cell infiltration levels also related to the prognosis of LUAD. We further revealed AURKA and FAM83A could be novel targets to improve the prognosis of LUAD through regulated the response to immunomodulators.

Keywords: lung adenocarcinoma, smoking, prognosis, tumor-infiltrating lymphocytes


Citation styles

APA
Zhang, M., Huo, C., Jiang, Y., Liu, J., Yang, Y., Yin, Y., Qu, Y. (2021). AURKA and FAM83A are prognostic biomarkers and correlated with Tumor-infiltrating Lymphocytes in smoking related Lung Adenocarcinoma. Journal of Cancer, 12(6), 1742-1754. https://doi.org/10.7150/jca.51321.

ACS
Zhang, M.; Huo, C.; Jiang, Y.; Liu, J.; Yang, Y.; Yin, Y.; Qu, Y. AURKA and FAM83A are prognostic biomarkers and correlated with Tumor-infiltrating Lymphocytes in smoking related Lung Adenocarcinoma. J. Cancer 2021, 12 (6), 1742-1754. DOI: 10.7150/jca.51321.

NLM
Zhang M, Huo C, Jiang Y, Liu J, Yang Y, Yin Y, Qu Y. AURKA and FAM83A are prognostic biomarkers and correlated with Tumor-infiltrating Lymphocytes in smoking related Lung Adenocarcinoma. J Cancer 2021; 12(6):1742-1754. doi:10.7150/jca.51321. https://www.jcancer.org/v12p1742.htm

CSE
Zhang M, Huo C, Jiang Y, Liu J, Yang Y, Yin Y, Qu Y. 2021. AURKA and FAM83A are prognostic biomarkers and correlated with Tumor-infiltrating Lymphocytes in smoking related Lung Adenocarcinoma. J Cancer. 12(6):1742-1754.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image